Routine dematerialization compliance certificate for Jul-Sep 2026 quarter

Compliance View source PDF Explain this filing

ABBOTINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹26130.00

prior close

₹26150.00

announcement price

After-mkt

timing

Nifty Midcap 150market-0.6%+0.5% vs market

Pharmaceuticals peers, median of 170sector-0.3%+0.2% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Midcap 150 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.2

15m

-0.3

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1-0.6+0.5-0.3+0.2

Next day

-2.3-3.0+0.7-2.7+0.5

-0.6-1.7+1.1-2.7+2.1

-1.3-1.6+0.4-2.6+1.4

-1.7-0.7-1.0-3.1+1.4

+1.3-0.7+2.0-3.0+4.3

+0.3-1.1+1.4-3.5+3.8

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Abbott India has submitted the quarterly certificate from its Registrar and Transfer Agent, KFin Technologies, under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The certificate confirms that all share certificates received for demat during the quarter were verified, confirmed to depositories, and the register of members updated within 30 days. This is a standard procedural compliance filing with no business or financial details.

Likely market impact

Routine regulatory compliance; no material impact on business, financials, or share price.